The antithrombotic potential of targeting the Factor IX-dependent coagulation pathway

Current Opinion in Cardiovascular, Pulmonary and Renal Investigational Drugs

Volumn 2, Issue 2, 2000, Pages 124-130

  Toomey, J R ^a   Blackburn, M N ^a   Feuerstein, G Z ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Antithrombotics; Coagulation; Faxtor IXa inhibitor; Monoclonal antibody

Indexed keywords

ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 9A; BLOOD CLOTTING INHIBITOR; CLOPIDOGREL; DIPYRIDAMOLE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MONOCLONAL ANTIBODY; WARFARIN;

ANIMAL MODEL; ANTICOAGULANT THERAPY; ANTICOAGULATION; BLOOD CLOTTING; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG TARGETING; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; RAT; REVIEW; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0034116353     PISSN: 14648482     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)